Literature DB >> 21397690

Microdialysis assessment of percutaneous penetration of ketoprofen after transdermal administration to hairless rats and domestic pigs.

Norihiro Shinkai1, Kazuko Korenaga, Yutaka Okumura, Hideo Mizu, Hitoshi Yamauchi.   

Abstract

The study was performed to evaluate the percutaneous penetration of ketoprofen after transdermal administration using a microdialysis technique in pigs, in comparison with rats. Ketoprofen release from patches was determined by analysis of the remaining drug content after application to hairless rats and pigs. Skin and knee joint penetration of ketoprofen was tested by microdialysis, and recovery was determined by retrodialysis. Residual rates in hairless rats and pigs were 68.1 ± 1.6% and 81.7 ± 4.4%, respectively, at 10h. The average recoveries of ketoprofen over 480 min in the skin and knee joint cases were 72.0 ± 3.4% and 9.8 ± 6.2% in rats and 72.3 ± 2.5% and 57.6 ± 3.1% in pigs, respectively. In rats, ketoprofen was rapidly absorbed with transdermal administration, with C(max) values of 191.7 ± 76.2 and 35.5 ± 21.7 ng/mL and AUC(0-8h) values of 918.2 ± 577.5 and 195.9 ± 137.1 ngh/mL, respectively, for the skin and knee joint. The C(max) values for the pig were 20.9 ± 18.5 and 3.7 ± 3.0 ng/mL, with AUC(0-8h) values of 73.1 ± 69.2 and 16.1 ± 16.1 ngh/mL. Ketoprofen concentrations within skin and knee joint of non-application sites in rats and pigs were less than 0.8 ng/mL. Transdermal administration of ketoprofen significantly reduced prostaglandin E2 levels in the skin of the application site and showed a tendency for inhibition in the knee joint. We thus demonstrated that topical patches containing ketoprofen can deliver the drug through the skin and knee joint of pigs and rats via direct diffusion, and microdialysis data with the pig may be useful for the prediction of human tissue penetration of drugs with transdermal administration.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21397690     DOI: 10.1016/j.ejpb.2011.03.005

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  7 in total

1.  Dermal microdialysis technique to evaluate the trafficking of surface-modified lipid nanoparticles upon topical application.

Authors:  Pinaki R Desai; Punit P Shah; Ram R Patlolla; Mandip Singh
Journal:  Pharm Res       Date:  2012-05-30       Impact factor: 4.200

2.  Skin permeating nanogel for the cutaneous co-delivery of two anti-inflammatory drugs.

Authors:  Punit P Shah; Pinaki R Desai; Apurva R Patel; Mandip S Singh
Journal:  Biomaterials       Date:  2011-11-26       Impact factor: 12.479

3.  Enhanced skin permeation using polyarginine modified nanostructured lipid carriers.

Authors:  Punit P Shah; Pinaki R Desai; Debra Channer; Mandip Singh
Journal:  J Control Release       Date:  2012-05-14       Impact factor: 9.776

4.  Blockade of leukocyte haptokinesis and haptotaxis by ketoprofen, diclofenac and SC-560.

Authors:  Saulius Paskauskas; Audrius Parseliunas; Vachtang Kerkadze; Rainer Nobiling; Jan Schmidt; Eduard Ryschich
Journal:  BMC Immunol       Date:  2011-11-12       Impact factor: 3.615

5.  Design of a transdermal formulation containing raloxifene nanoparticles for osteoporosis treatment.

Authors:  Noriaki Nagai; Fumihiko Ogata; Hiroko Otake; Yosuke Nakazawa; Naohito Kawasaki
Journal:  Int J Nanomedicine       Date:  2018-09-06

6.  Development and Evaluation of Novel Water-Based Drug-in-Adhesive Patches for the Transdermal Delivery of Ketoprofen.

Authors:  Kwanputtha Arunprasert; Chaiyakarn Pornpitchanarong; Theerasak Rojanarata; Tanasait Ngawhirunpat; Praneet Opanasopit; Porawan Aumklad; Prasopchai Patrojanasophon
Journal:  Pharmaceutics       Date:  2021-05-25       Impact factor: 6.321

7.  Pharmacokinetic Evaluation of a Novel Transdermal Ketoprofen Formulation in Healthy Dogs.

Authors:  Halley Gora Ravuri; Nana Satake; Alexandra Balmanno; Jazmine Skinner; Samantha Kempster; Paul C Mills
Journal:  Pharmaceutics       Date:  2022-03-15       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.